2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 3, 2003, Pages 413-417

  Joo, Yung Hyup ^a   Kim, Jin Kwan ^a   Kang, Seon Hwa ^a   Noh, Min Soo ^a   Ha, Jun Yong ^a   Choi, Jin Kyu ^a   Lim, Kyung Min ^a   Lee, Chang Hoon ^a   Chung, Shin ^a  

^a AmorePacific Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BENZOPYRAN DERIVATIVE; CYCLOOXYGENASE 2 INHIBITOR; FLAVONE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; NONHUMAN; PAW EDEMA; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPYRANS; CARRAGEENAN; CHEMISTRY, PHYSICAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; EDEMA; INDICATORS AND REAGENTS; ISOENZYMES; MALE; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0037330939     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00952-6     Document Type: Article

References (19)

1. DeWitt D.L. Mol, Pharmacol. 55:1999;625.
2. (a) Fu J.-Y., Masferrer J.L., Seibert K., Raz A., Needleman P. J. Biol. Chem. 265:1990;16737
3. (b) Xie W., Chipman J.G., Robertson D.L., Erikson R.L., Simmons D.L. Proc. Natl. Acad. Sci. U.S.A. 88:1991;2692.
4. (a) Talley J.J., Bertenshaw S.R., Brown D.L., Carter J.S., Graneto M.J., Kellog M.S., Koboldt C.M., Yuan J., Zhang Y.Y., Seibert K. J. Med. Chem. 43:2000;1661
5. (b) Talley J.J., Brown D.L., Carter J.S., Graneto M.J., Koboldt C.M., Masferrer J.L., Perkin W.E., Rogers R.S., Shaffer A.F., Zhang Y.Y., Zweifel B.S., Seibert K. J. Med. Chem. 43:2000;775
6. (c) Shin S.S., Noh M., Byun Y.J., Choi J.K., Kim J.Y., Lim K.M., Ha J., Kim J.K., Lee C.H., Chung S. Bioorg. Med. Chem. Lett. 11:2001;165
7. (d) Hashimoto H., Imamura K., Haruta J., Wakitani K. J. Med. Chem. 45:2002;1511.
8. (a) Iqbal J., Fatma W., Shaida W.A., Rahman W. J. Chem. Research(S). 92:1982;
9. (b) Makrandi J.K. Seema. Chem. & Ind. 607:1989.
10. (a) Miyaura N., Yanagi T., Suzuki A. Synth. Commun. 11:1981;513
11. (b) Hoshino Y., Miyaura N., Suzuki A. Bull. Chem. Soc. Jpn. 61:1988;3008
12. (c) Watanabe T., Miyaura N., Suzuki A. Synlett. 207:1992.
13. Selected compounds were prepared as follows.
14. Pawda A., Gunn D.E., Osterhout M.H. Synthesis. 1353:1997.
15. Mtchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Proc. Natl. Acad. Sci. U.S.A. 90:1994;11693.
16. Khanna I.K., Weier R.M., Yu Y., Xu X.D., Koszyk F.J., Collins P.W., Koboldt C.M., Veenhuizen A.W., Perkins W.E., Casler J.J., Masferrer J.L., Zhang Y.Y., Gregory S.A., Seibert K., Isakson P.C. J. Med. Chem. 40:1997;1634.
17. Futaki N., Yoshikawa K., Hamasaka Y., Arai I., Higuchi S., Iizuka H., Otomo S. Gen. Pharmacol. 24:1993;105.
18. Lewis E.J., Bishop J., Aspinall S.J. Inflamm. Res. 47:1998;26.
19. Griffiths L.A., Smith G.E. Biochem. J. 128:1972;901.